Center for Transformative Nanomedicine (CTN)

For Cleveland Clinic and Hebrew University of Jerusalem


The Center for Transformative Nanomedicine (CTN)
Announces the Request for Applications (RFA) for the first funding cycle 
For Cleveland Clinic and Hebrew University of Jerusalem

Funding is available for promising emerging technologies directed towards diagnosis, treatment or management of cardiovascular, cancer, immune diseases, or neurological disorders.  We are seeking projects such as therapeutics (e.g. drugs, biologics), diagnostics, diagnostic systems, devices, tools, etc., in order to facilitate their translation to commercialized products that improve patient care and enhance health.

The CTN will provide funding and project assistance to advance the development of high priority early-stage technologies.

Expert assistance will be provided in areas required for early technology development, including commercial opportunity assessment, intellectual property, clinical and regulatory, reimbursement, business, legal and project management.

See the current Funding Opportunity Announcement and related documents linked below for details.


Full project application

If you have difficulty accessing the files, please right-click on the requested link & select "save target as…" in order to save the document.